Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
Clinical trial NCT01822314 · COMPLETED
Trial details
- NCT number
- NCT01822314
- Sponsor
- Fondazione Michelangelo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.